PCH2_HUMAN - dbPTM
PCH2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PCH2_HUMAN
UniProt AC Q15645
Protein Name Pachytene checkpoint protein 2 homolog
Gene Name TRIP13
Organism Homo sapiens (Human).
Sequence Length 432
Subcellular Localization
Protein Description Plays a key role in chromosome recombination and chromosome structure development during meiosis. Required at early steps in meiotic recombination that leads to non-crossovers pathways. Also needed for efficient completion of homologous synapsis by influencing crossover distribution along the chromosomes affecting both crossovers and non-crossovers pathways. Also required for development of higher-order chromosome structures and is needed for synaptonemal-complex formation. In males, required for efficient synapsis of the sex chromosomes and for sex body formation. Promotes early steps of the DNA double-strand breaks (DSBs) repair process upstream of the assembly of RAD51 complexes. Required for depletion of HORMAD1 and HORMAD2 from synapsed chromosomes (By similarity). Plays a role in mitotic spindle assembly checkpoint (SAC) activation. [PubMed: 28553959]
Protein Sequence MDEAVGDLKQALPCVAESPTVHVEVHQRGSSTAKKEDINLSVRKLLNRHNIVFGDYTWTEFDEPFLTRNVQSVSIIDTELKVKDSQPIDLSACTVALHIFQLNEDGPSSENLEEETENIIAANHWVLPAAEFHGLWDSLVYDVEVKSHLLDYVMTTLLFSDKNVNSNLITWNRVVLLHGPPGTGKTSLCKALAQKLTIRLSSRYRYGQLIEINSHSLFSKWFSESGKLVTKMFQKIQDLIDDKDALVFVLIDEVESLTAARNACRAGTEPSDAIRVVNAVLTQIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPSAAAIFKIYLSCLEELMKCQIIYPRQQLLTLRELEMIGFIENNVSKLSLLLNDISRKSEGLSGRVLRKLPFLAHALYVQAPTVTIEGFLQALSLAVDKQFEERKKLAAYI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDEAVGDL
-------CCCHHHHH
10.6922223895
9SumoylationDEAVGDLKQALPCVA
CCHHHHHHHHCHHEE
37.96-
18PhosphorylationALPCVAESPTVHVEV
HCHHEECCCEEEEEE
19.0130266825
20PhosphorylationPCVAESPTVHVEVHQ
HHEECCCEEEEEEEE
32.3030266825
30PhosphorylationVEVHQRGSSTAKKED
EEEEECCCCCCCHHH
27.0629214152
31PhosphorylationEVHQRGSSTAKKEDI
EEEECCCCCCCHHHC
34.9029214152
32PhosphorylationVHQRGSSTAKKEDIN
EEECCCCCCCHHHCC
44.1626055452
34UbiquitinationQRGSSTAKKEDINLS
ECCCCCCCHHHCCHH
57.70-
35UbiquitinationRGSSTAKKEDINLSV
CCCCCCCHHHCCHHH
59.1429967540
41PhosphorylationKKEDINLSVRKLLNR
CHHHCCHHHHHHHHH
18.5221815630
56PhosphorylationHNIVFGDYTWTEFDE
CCCEEECCEECCCCC
12.4522817900
72PhosphorylationFLTRNVQSVSIIDTE
CCCCCCEEEEEEEEE
17.3529214152
74PhosphorylationTRNVQSVSIIDTELK
CCCCEEEEEEEEEEE
21.0521712546
81UbiquitinationSIIDTELKVKDSQPI
EEEEEEEEECCCCCC
40.7921963094
83UbiquitinationIDTELKVKDSQPIDL
EEEEEEECCCCCCCH
50.5022817900
147PhosphorylationVYDVEVKSHLLDYVM
EEEHHHHHHHHHHHH
25.2520068231
152PhosphorylationVKSHLLDYVMTTLLF
HHHHHHHHHHHHHHC
7.6523898821
155PhosphorylationHLLDYVMTTLLFSDK
HHHHHHHHHHHCCCC
12.3020068231
156PhosphorylationLLDYVMTTLLFSDKN
HHHHHHHHHHCCCCC
11.9023898821
160PhosphorylationVMTTLLFSDKNVNSN
HHHHHHCCCCCCCCC
47.8723898821
183PhosphorylationLLHGPPGTGKTSLCK
EECCCCCCCHHHHHH
41.08-
185UbiquitinationHGPPGTGKTSLCKAL
CCCCCCCHHHHHHHH
34.4827667366
185 (in isoform 1)Ubiquitination-34.4821890473
190UbiquitinationTGKTSLCKALAQKLT
CCHHHHHHHHHHHHH
52.2922817900
190AcetylationTGKTSLCKALAQKLT
CCHHHHHHHHHHHHH
52.2927452117
195UbiquitinationLCKALAQKLTIRLSS
HHHHHHHHHHHEHHH
41.8327667366
206PhosphorylationRLSSRYRYGQLIEIN
EHHHCCCCCEEEEEC
10.57-
216PhosphorylationLIEINSHSLFSKWFS
EEEECCHHHHHHHHH
30.82-
219PhosphorylationINSHSLFSKWFSESG
ECCHHHHHHHHHHHC
33.9824719451
227AcetylationKWFSESGKLVTKMFQ
HHHHHHCHHHHHHHH
49.4127452117
227 (in isoform 1)Ubiquitination-49.4121890473
227UbiquitinationKWFSESGKLVTKMFQ
HHHHHHCHHHHHHHH
49.4122817900
231UbiquitinationESGKLVTKMFQKIQD
HHCHHHHHHHHHHHH
30.1822817900
235UbiquitinationLVTKMFQKIQDLIDD
HHHHHHHHHHHHCCC
30.9429967540
288 (in isoform 1)Ubiquitination-38.1221890473
288UbiquitinationLTQIDQIKRHSNVVI
HHHHHHHHHHCCEEE
38.1221963094
2882-HydroxyisobutyrylationLTQIDQIKRHSNVVI
HHHHHHHHHHCCEEE
38.12-
291PhosphorylationIDQIKRHSNVVILTT
HHHHHHHCCEEEEEC
35.0430576142
297PhosphorylationHSNVVILTTSNITEK
HCCEEEEECCCCCCE
19.6320860994
298PhosphorylationSNVVILTTSNITEKI
CCEEEEECCCCCCEE
19.1420860994
316 (in isoform 1)Ubiquitination-37.2821890473
316UbiquitinationFVDRADIKQYIGPPS
EECHHHHHHHHCCHH
37.2821963094
318PhosphorylationDRADIKQYIGPPSAA
CHHHHHHHHCCHHHH
11.6624043423
323PhosphorylationKQYIGPPSAAAIFKI
HHHHCCHHHHHHHHH
33.4020446291
331PhosphorylationAAAIFKIYLSCLEEL
HHHHHHHHHHHHHHH
7.9824043423
333PhosphorylationAIFKIYLSCLEELMK
HHHHHHHHHHHHHHC
10.3224043423
340UbiquitinationSCLEELMKCQIIYPR
HHHHHHHCCCCCCCH
35.3021963094
345PhosphorylationLMKCQIIYPRQQLLT
HHCCCCCCCHHHHHH
8.2624043423
358SulfoxidationLTLRELEMIGFIENN
HHHHHHHHHCCCCCC
5.9221406390
367PhosphorylationGFIENNVSKLSLLLN
CCCCCCHHHHHHHHH
29.9721712546
370PhosphorylationENNVSKLSLLLNDIS
CCCHHHHHHHHHHHH
22.2521712546
377PhosphorylationSLLLNDISRKSEGLS
HHHHHHHHHCCCCCC
36.2021406692
380PhosphorylationLNDISRKSEGLSGRV
HHHHHHCCCCCCHHH
35.4720068231
384PhosphorylationSRKSEGLSGRVLRKL
HHCCCCCCHHHHHHH
35.1020068231

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PCH2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PCH2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PCH2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CK054_HUMANC11orf54physical
16189514
GRIN2_HUMANGPRIN2physical
16189514
TEX37_HUMANTEX37physical
16189514
ASB13_HUMANASB13physical
16189514
PCH2_HUMANTRIP13physical
16189514
MD2BP_HUMANMAD2L1BPphysical
16189514
NB5R2_HUMANCYB5R2physical
16189514
STALP_HUMANSTAMBPL1physical
16189514
HDHD3_HUMANHDHD3physical
16189514
GPSM1_HUMANGPSM1physical
16189514
CAR14_HUMANCARD14physical
16189514
ZN655_HUMANZNF655physical
16189514
TLDC1_HUMANTLDC1physical
16189514
LNX1_HUMANLNX1physical
16189514
RBPMS_HUMANRBPMSphysical
16189514
DTX2_HUMANDTX2physical
16189514
PLS4_HUMANPLSCR4physical
16189514
GLCTK_HUMANGLYCTKphysical
16189514
DDAH2_HUMANDDAH2physical
16189514
LOXL4_HUMANLOXL4physical
16189514
SC24A_HUMANSEC24Aphysical
16189514
SMUG1_HUMANSMUG1physical
16189514
PLAC8_HUMANPLAC8physical
16189514
PBLD_HUMANPBLDphysical
16189514
NIF3L_HUMANNIF3L1physical
16189514
SEM4G_HUMANSEMA4Gphysical
16189514
PLS3_HUMANPLSCR3physical
16189514
INT11_HUMANCPSF3Lphysical
16189514
NTAQ1_HUMANWDYHV1physical
16189514
KRA32_HUMANKRTAP3-2physical
16189514
ARL11_HUMANARL11physical
16189514
DPYL1_HUMANCRMP1physical
16169070
PCH2_HUMANTRIP13physical
16169070
UBA1_HUMANUBA1physical
22939629
TTC37_HUMANTTC37physical
22939629
ADPPT_HUMANAASDHPPTphysical
22863883
S10A4_HUMANS100A4physical
22863883
NIPA_HUMANZC3HC1physical
22863883
PCH2_HUMANTRIP13physical
25416956
DPYL4_HUMANDPYSL4physical
25416956
DIP2A_HUMANDIP2Aphysical
25416956
TNR6A_HUMANTNRC6Aphysical
25416956
NAGA_HUMANAMDHD2physical
25416956
NB5R2_HUMANCYB5R2physical
25416956
PCMD2_HUMANPCMTD2physical
25416956
PLS3_HUMANPLSCR3physical
25416956
PELI1_HUMANPELI1physical
25416956
SPRY7_HUMANSPRYD7physical
25416956
SEM4G_HUMANSEMA4Gphysical
25416956
PBLD_HUMANPBLDphysical
25416956
TINAL_HUMANTINAGL1physical
25416956
FND3B_HUMANFNDC3Bphysical
25416956
ZNF34_HUMANZNF34physical
25416956
LOXL4_HUMANLOXL4physical
25416956
RHXF2_HUMANRHOXF2physical
25416956
LNX1_HUMANLNX1physical
25416956
LLR1_HUMANLRR1physical
25416956
M1AP_HUMANM1APphysical
25416956
GLCTK_HUMANGLYCTKphysical
25416956
CD033_HUMANC4orf33physical
25416956
MGT5B_HUMANMGAT5Bphysical
25416956
MET15_HUMANMETTL15physical
25416956
TEX37_HUMANTEX37physical
25416956
MORN3_HUMANMORN3physical
25416956
KR122_HUMANKRTAP12-2physical
25416956
KR121_HUMANKRTAP12-1physical
25416956
KR261_HUMANKRTAP26-1physical
25416956
MSH2_HUMANMSH2physical
26344197
TADBP_HUMANTARDBPphysical
26344197
TTC4_HUMANTTC4physical
26344197
MD2BP_HUMANMAD2L1BPphysical
26324890
MD2L1_HUMANMAD2L1physical
26324890
BUB1B_HUMANBUB1Bphysical
26324890
CDC20_HUMANCDC20physical
26324890
PCH2_HUMANTRIP13physical
26324890
MTG1_HUMANMTG1physical
28514442
PUSL1_HUMANPUSL1physical
28514442
ADAT3_HUMANADAT3physical
28514442
QOR_HUMANCRYZphysical
28514442
P4K2B_HUMANPI4K2Bphysical
28514442
INT11_HUMANCPSF3Lphysical
28514442

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PCH2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-56, AND MASSSPECTROMETRY.

TOP